Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-8-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0435-1339
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
225
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2501136-Bile Ducts,
pubmed-meshheading:2501136-HLA Antigens,
pubmed-meshheading:2501136-Humans,
pubmed-meshheading:2501136-Immunoenzyme Techniques,
pubmed-meshheading:2501136-Interferon-gamma,
pubmed-meshheading:2501136-Interleukin-2,
pubmed-meshheading:2501136-Liver Cirrhosis, Biliary
|
pubmed:year |
1989
|
pubmed:articleTitle |
Interferon gamma and bile duct damage in primary biliary cirrhosis.
|
pubmed:affiliation |
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|